HIV-1 replication and potential targets for intervention
- PMID: 1540400
- DOI: 10.1089/aid.1992.8.107
HIV-1 replication and potential targets for intervention
Abstract
Intense research into fundamental processes of human immunodeficiency syndrome type 1 (HIV-1) replication has yielded knowledge that in many aspects equals or exceeds that of the oncogenic retroviruses. The availability of sensitive virus detection methods has allowed a more thorough characterization of the biology of virus persistence and latency in vivo and removed the dependence on in vitro models. As a clearer picture of the pattern of HIV-1 replication in vivo evolves, it becomes apparent that HIV-1 biology is distinct from that of the prototypic oncogenic retroviruses in several key aspects, particularly with regard to host cell range and determinants of viral permissiveness. In this respect it may be appropriate to examine the lentivirus, rather than the oncovirus model system to better understand the biology and pathogenesis of HIV-1 infection. This synopsis of recent and ongoing research developments in HIV-1 replication and pathogenesis emphasizes the determinants of host cell permissiveness, early events in virus replication, and underlying features in HIV-1 cytopathogenesis. In addition, basic viral replication processes which can be exploited for therapeutic intervention are discussed.
Similar articles
-
Controlling elements in replication of the human immunodeficiency virus type 1.Cell Mol Biol (Noisy-le-grand). 1997 May;43(3):443-54. Cell Mol Biol (Noisy-le-grand). 1997. PMID: 9193800 Review.
-
Identification of HIV-1 vpr product and function.J Acquir Immune Defic Syndr (1988). 1990;3(1):11-8. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2136707
-
Host factors exploited by retroviruses.Nat Rev Microbiol. 2007 Apr;5(4):253-63. doi: 10.1038/nrmicro1541. Epub 2007 Feb 26. Nat Rev Microbiol. 2007. PMID: 17325726 Review.
-
The gene expression of human foamy virus does not require a post-transcriptional transactivator.Virology. 1994 Oct;204(1):409-13. doi: 10.1006/viro.1994.1545. Virology. 1994. PMID: 7522374
-
[Pathogenesis of human immunodeficiency virus infection].Rev Invest Clin. 1994 Mar-Apr;46(2):113-47. Rev Invest Clin. 1994. PMID: 8052741 Review. Spanish.
Cited by
-
Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.J Virol. 1995 May;69(5):2977-88. doi: 10.1128/JVI.69.5.2977-2988.1995. J Virol. 1995. PMID: 7707524 Free PMC article.
-
Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.Antimicrob Agents Chemother. 1998 Mar;42(3):487-94. doi: 10.1128/AAC.42.3.487. Antimicrob Agents Chemother. 1998. PMID: 9517921 Free PMC article.
-
Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.Mol Med. 1995 Jan;1(2):217-30. Mol Med. 1995. PMID: 8529100 Free PMC article.
-
Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.J Virol. 1995 Mar;69(3):1794-801. doi: 10.1128/JVI.69.3.1794-1801.1995. J Virol. 1995. PMID: 7853519 Free PMC article.
-
Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).Drugs. 1993 May;45(5):637-53. doi: 10.2165/00003495-199345050-00002. Drugs. 1993. PMID: 7686460 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials